CVS Health 與禮來($LLY)擴大 GLP-1 藥物供應合作

· seekingalpha.com

CVS Health (CVS) 與禮來公司 (Eli Lilly, $LLY) 展開合作,透過 CVS 應用程式擴大供應這家總部位於印第安納州企業旗下的 Zepbound 與 Mounjaro 等 GLP-1 藥物。點擊此處閱讀更多資訊。

CVS Health (CVS) on Wednesday announced a collaboration with Eli Lilly (LLY) to allow patients to more easily access the Indiana-based drugmaker’s weight loss...


More AI market news · Market heatmap · StrategyVerse · Quant Research · WOBR.AI